KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EverQuote (EVER) Common Equity (2017 - 2025)

EverQuote (EVER) has disclosed Common Equity for 9 consecutive years, with $238.0 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 75.85% to $238.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $238.0 million through Dec 2025, up 75.85% year-over-year, with the annual reading at $238.0 million for FY2025, 75.85% up from the prior year.
  • Common Equity hit $238.0 million in Q4 2025 for EverQuote, up from $174.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $238.0 million in Q4 2025 to a low of $76.0 million in Q1 2021.
  • Historically, Common Equity has averaged $115.4 million across 5 years, with a median of $105.9 million in 2022.
  • Biggest five-year swings in Common Equity: dropped 24.73% in 2023 and later skyrocketed 75.85% in 2025.
  • Year by year, Common Equity stood at $85.1 million in 2021, then grew by 26.27% to $107.5 million in 2022, then decreased by 24.73% to $80.9 million in 2023, then soared by 67.31% to $135.4 million in 2024, then surged by 75.85% to $238.0 million in 2025.
  • Business Quant data shows Common Equity for EVER at $238.0 million in Q4 2025, $174.9 million in Q3 2025, and $170.3 million in Q2 2025.